Charles River Laboratories
677 hedge funds and large institutions have $14.1B invested in Charles River Laboratories in 2024 Q1 according to their latest regulatory filings, with 93 funds opening new positions, 256 increasing their positions, 229 reducing their positions, and 47 closing their positions.
98% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 47
88% more funds holding in top 10
Funds holding in top 10: 8 → 15 (+7)
12% more repeat investments, than reductions
Existing positions increased: 256 | Existing positions reduced: 229
7% more funds holding
Funds holding: 634 → 677 (+43)
0% more capital inflows, than outflows
Capital inflows: $1.01B | Capital outflows: $1.01B
0.11% less ownership
Funds ownership: 101.83% → 101.73% (-0.11%)
47% less call options, than puts
Call options by funds: $52M | Put options by funds: $98.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$158M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$61.9M |
| 3 |
Epoch Investment Partners
New York
|
+$57M |
| 4 |
Employees Retirement System of Texas
Austin,
Texas
|
+$41.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$36.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TPG GP A
Fort Worth,
Texas
|
-$101M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$87.2M |
| 3 |
Southpoint Capital Advisors
New York
|
-$71.6M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$63.4M |
| 5 |
Neuberger Berman Group
New York
|
-$59.3M |
CRL Hedge Fund Activity: Q1 2024 in Review
677 of the 6,966 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2024, worth a combined $14.1B — up 15% from $12.3B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new CRL positions and 47 closed out — a net gain of 46 holders — while 256 added to existing stakes and 229 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $158M. The largest seller was TPG GP A, exiting entirely with an estimated $101M sold.
- 677 institutional investors held Charles River Laboratories (CRL) as of Q1 2024, up from 634 in Q4 2023.
- Funds reported $14.1B of Charles River Laboratories stock for Q1 2024, up 15% quarter-over-quarter.
- 93 funds opened new Charles River Laboratories positions in Q1 2024 and 47 closed out, a net change of +46 holders.
- The largest Charles River Laboratories buyer in Q1 2024 was Marshall Wace, an estimated $158M added.
- The largest Charles River Laboratories seller in Q1 2024 was TPG GP A, an estimated $101M sold.
Based on aggregated 13F filings for Q1 2024.